Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging functions of C/EBPβ in breast cancer
Megan G. Matherne, Emily S. Phillips, Samuel J. Embrey, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 18

Showing 18 citing articles:

Nucleosome reorganisation in breast cancer tissues
Divya R. Jacob, Wilfried M. Guiblet, Hulkar Mamayusupova, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma
Maria C. Gelmi, Gülçin Gezgin, Pieter A. van der Velden, et al.
Investigative Ophthalmology & Visual Science (2023) Vol. 64, Iss. 15, pp. 36-36
Open Access | Times Cited: 11
Interplay of p62-mTORC1 and EGFR signaling promotes cisplatin resistance in oral cancer
Hsiu‐Chuan Chang, Cheng‐Chieh Yang, Lai‐Keng Loi, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e28406-e28406
Open Access | Times Cited: 4
Design and Evaluation of RNA Aptamer–Mediated Delivery of C/EBPβ siRNA for Oncological Therapy
Daniel Vasconcelos, Mikael H. Sodergren, Vikash Reebye, et al.
Journal of Nucleic Acids (2025) Vol. 2025, Iss. 1
Open Access
A single-cell network approach to decode metabolic regulation in gynecologic and breast cancers
Akansha Srivastava, P. K. Vinod
npj Systems Biology and Applications (2025) Vol. 11, Iss. 1
Open Access
Precision peptide disruptors: The next generation of targeted therapeutics in oncology
Bria O'Gorman, Sean F. Cooke, Connor M. Blair
Cellular Signalling (2025), pp. 111783-111783
Open Access
Anoikis Resistance in Cancer: Mechanisms, Therapeutic Strategies, Potential Targets, and Models for Enhanced Understanding
Pallab Shaw, Arpan Dey Bhowmik, Mohan Shankar Gopinatha Pillai, et al.
Cancer Letters (2025), pp. 217750-217750
Closed Access
NAT10/CEBPB/vimentin signalling axis promotes adenoid cystic carcinoma malignant phenotypes in vitro
Min Fu, Qian Gao, Mian Xiao, et al.
Oral Diseases (2024) Vol. 30, Iss. 7, pp. 4341-4355
Closed Access | Times Cited: 3
CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer
Xueying Yuan, Xiaoxin Hao, Hilda L. Chan, et al.
JCI Insight (2024) Vol. 9, Iss. 20
Open Access | Times Cited: 2
Syntaxin4, P-cadherin, and CCAAT enhancer binding protein β as signaling elements in the novel differentiation pathway for cultured embryonic stem cells
Shuji Matsuguchi, Yohei Hirai
Biochemical and Biophysical Research Communications (2023) Vol. 672, pp. 27-35
Closed Access | Times Cited: 4
C/EBPβ deletion in macrophages impairs mammary gland alveolar budding during the estrous cycle
Michelle D. Rojo, Ishitri Bandyopadhyay, Caitlin M. Burke, et al.
Life Science Alliance (2024) Vol. 7, Iss. 10, pp. e202302516-e202302516
Open Access | Times Cited: 1
Mucosa-like differentiation of head and neck cancer cells is inducible and drives the epigenetic loss of cell malignancy
Felix Oppel, Sarah Gendreizig, Laura Martinez‐Ruiz, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 1
CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC
Xueying Yuan, Xiaoxin Hao, Hilda L. Chan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
CEBPBas a potential biomarker for prognosis and immune infiltration in clear cell renal cell carcinoma
Yaoqiang Ren, Baoping Qiao, Min Wei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
N-terminal acetylation of transcription factor LIP induces immune therapy resistance via suppression of PD-L1 expression in non-small cell lung cancer
Xiang He, Yongshuo Liu, Xing Gao, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e009905-e009905
Open Access
Disrupting Notch signaling related HES1 in myeloid cells reinvigorates antitumor T cell responses
Myung Sup Kim, Hyeok-Gu Kang, Jung-Hwan Baek, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access
Emerging Signatures of Hematological Malignancies from Gene Expression and Transcription Factor-Gene Regulations
Daniele Dall’Olio, Federico Magnani, Francesco Casadei, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13588-13588
Open Access
Inducible mucosa-like differentiation of head and neck cancer cells drives the epigenetically determined loss of cell malignancy
Felix Oppel, Sarah Gendreizig, Laura Martinez‐Ruiz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
P53 regulates CCAAT/Enhancer binding protein β gene expression
Biao Hu, Tianju Liu, Zhe Wu, et al.
Gene (2023) Vol. 884, pp. 147675-147675
Closed Access | Times Cited: 1
Page 1

Scroll to top